Response to therapy and survival statistics
| Variable . | All5-150 (n = 336) . | t(11;14) (q13;q32) (n = 53) . | Other (n = 268) . |
|---|---|---|---|
| Response rate | |||
| Objective response | 67.2 | 73.6 | 66.0 |
| None/progression | 31.1 | 20.7 | 32.9 |
| Not evaluable | 1.7 | 5.6 | 1.1 |
| Median survival, mo (95% confidence interval) | 40.5 (36.9-46.7) | 49.6 (36.9-60.1) | 38.7 (35.5-43.7) |
| Progression-free survival, mo (95% confidence interval) | 28.9 (26-31.9) | 33.0 (27.6-43.3) | 27.1 (24.4-31.1) |
| Variable . | All5-150 (n = 336) . | t(11;14) (q13;q32) (n = 53) . | Other (n = 268) . |
|---|---|---|---|
| Response rate | |||
| Objective response | 67.2 | 73.6 | 66.0 |
| None/progression | 31.1 | 20.7 | 32.9 |
| Not evaluable | 1.7 | 5.6 | 1.1 |
| Median survival, mo (95% confidence interval) | 40.5 (36.9-46.7) | 49.6 (36.9-60.1) | 38.7 (35.5-43.7) |
| Progression-free survival, mo (95% confidence interval) | 28.9 (26-31.9) | 33.0 (27.6-43.3) | 27.1 (24.4-31.1) |
Includes patients with failed FISH assay.